Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
Study NCT ID:
NCT00481767
Status:
COMPLETED
Last Update Posted:
2020-11-17
First Post:
2007-05-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-10-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-02-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-07-26
Completion Date Type:
ACTUAL
First Submit Date:
2007-05-31
First Submit QC Date:
None
Study First Post Date:
2007-06-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-02-24
Results First Submit QC Date:
None
Results First Post Date:
2011-03-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-26
Last Update Post Date:
2020-11-17
Last Update Post Date Type:
ACTUAL